Jump to the top of the page

Showing 1150 – 1160 of 1307 results

  • Enfusion Inc Initiation

    William Blair initiated research coverage of Enfusion, Inc. (ENFN $22.52), a leading provider of SaaS-based investment operations management software.

  • MiNK Therapeutics Inc Initiation

    William Blair initiated research coverage of MiNK Therapeutics, Inc. (INKT $17.38). MiNK Therapeutics is focused on the development of invariant natural killer T (iNKT) cell-based therapies for the treatment of cancers and autoimmune diseases.

  • Alector Inc Initiation

    William Blair initiated research coverage of Alector, Inc. (ALEC $24.26), a clinical-stage biopharma company developing therapies that target neuro-immunology using genetic insights in chronic neurodegenerative disorders.

  • AgileThought Inc Initiation

    William Blair initiated research coverage of AgileThought, Inc. (AGIL $9.53), a digital transformation and agile software development service provider for Fortune 1,000 customers. The company is based in Irving, Texas, and has several delivery centers in Mexico, Brazil, Argentina, Costa Rica, and the United States.

  • ForgeRock Inc Initiation

    William Blair initiated research coverage of ForgeRock, Inc. (FORG $33.80), a leading provider of identity access management solutions that help enterprises manage, secure, govern, and streamline their identity infrastructure.

  • Dutch Bros Inc Initiation

    William Blair initiated research coverage of Dutch Bros Inc. (BROS $25.95), a rapidly growing owner and franchisor of drive-thru locations offering a wide variety of customizable beverages, including espresso-based beverages and its proprietary Blue Rebel energy drinks.

  • Initiation

    William Blair initiated research coverage of CCC Intelligent Solutions Holdings Inc. (CCCS $10.73), a leading cloud-based platform supporting the automotive claims ecosystem.

  • uniQure NV Initiation

    William Blair initiated research coverage of uniQure N.V. (QURE $29.36). Based in the Netherlands, uniQure N.V. is focused on developing and commercializing adeno-associated virus (AAV) gene therapies for the treatment of severe genetic disorders of the liver and CNS.

  • DigitalOcean Holdings Inc Initiation

    William Blair initiated research coverage of DigitalOcean Holdings, Inc. (DOCN $107.69), which provides a comprehensive cloud platform designed to simplify cloud infrastructure for developers, start-ups, and small to midsize businesses.

  • Portillos Inc Initiation

    William Blair initiated research coverage of Portillo’s Inc. (PTLO $44.83), a growing chain of high-volume, limited-service restaurants serving a menu centered on Chicago favorites such as Italian beef and Chicago-style hot dogs and sausages.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures